Clinical trial
Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute…
NCT00099788 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT00099788 |
|---|---|
| Title | Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes |
| Official title | A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multinational, Clinical Trial to Evaluate the Efficacy and Safety of Ranolazine vs Placebo in Patients With Non-ST Segment Elevation Acute Coronary Syndromes |
| Lead sponsor | Gilead Sciences, Industry |
| Collaborators | The TIMI Study Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Ischemia |
| Intervention type | Drug |
| Interventions | Ranolazine, Placebo |
| Enrollment | 6,560 |
| Start date | Oct 1, 2004 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Dec 21, 2004 |
| Last update posted | Nov 26, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: